Live
FierceBiotechJenaValve's Trilogy valve secures FDA's 1st approval in aortic regurgitationFierceBiotechStroke tech developer Imperative Care nets $100M financingFierceBiotechCrossbow hits $77M series B round to bankroll quiver of T-BoltsBioPharma DiveAspen’s fresh Parkinson’s data; Aldeyra tanks following FDA rejectionLonza NewsLonza to relocate around 40 jobs from Switzerland to India - SWI swissinfo.chEndpoints NewsAI startup Basecamp Research announces trillion-gene project10x Genomics Blog10x Genomics shows market leadership with jump to 92 RS rating - MSNEndpoints NewsIonis delays prion disease readout; Arvinas' Parkinson's biomarker dataIlluminaIllumina and Labcorp expand cancer testing collaboration - Investing.comEndpoints NewsFDA approves J&J's psoriasis pill Icotyde with $5B+ peak sales potentialIlluminaLabcorp–Illumina cancer pact targets wider access to genomic tests - Stock TitanIlluminaIllumina and Labcorp expand collaboration to broaden access to precision oncology testing - PR Newswire
Endpoints News Jan 30, 2026

Ultragenyx resubmits gene therapy for rare neuro disease to FDA

Ultragenyx resubmits gene therapy for rare neuro disease to FDA

Original
Body unavailable. Use the original source.

Directory

59 All